Treating Severe COVID-19 Could Be Just “The Tip Of The Iceberg” For This Biotech Up 38,000%
The small Swiss biotech firm featured in today’s article has been developing a drug that could help patients suffering from severe COVID-19 – and with…
COVID-19 Vaccine
An Options Strategy For This COVID Vaccine Play With More Room To Run
When it comes to COVID-19 vaccine manufacturers, the author of today’s article notes “While it’s no surprise that investors have already bought into these companies,…
These Biotechs Are Awaiting FDA Rulings In November
October has seen the FDA approve the first drug for COVID-19 (remdesivir), the first treatment for Ebola virus (Regeneron Pharmaceuticals’ Inmazeb), and the first drug…
Is The Stage Being Set For A Strong Biotech Rally?
Amid setbacks for various potential COVID-19 vaccines and treatments, election risk, strengthening M&A activity, and more, what’s the outlook for healthcare and biotech in the…
The Current Status – And Future Prospects – Of This COVID-19 Vaccine Partnership
In March, two small biotechs partnered to develop a vaccine for COVID-19 using a mechanism called RNA interference (RNAi) – and early data for the…
These 2 Biotechs Could Revolutionize Disease Treatment And Prevention – And Bring Big Rewards To Risk-Tolerant Investors
“One method of finding great stocks is to hunt down clinical stage companies with potential new treatment methods for diseases and ailments that affect large…
Why A COVID-19 Vaccine Could Be Approved Before The November Election – And Who The Real Winners Would Be
Could a COVID-19 vaccine – or vaccines – be approved before the November election? That’s the bold prediction being made by Jefferies – and if…